Nova Laboratories Ireland Limited - Výsledky vyhľadávania

Európska únia - slovenčina - EMA (European Medicines Agency)

xaluprine (previously mercaptopurine nova laboratories)

nova laboratories ireland limited - 6-merkaptopurín monohydrát - leukémia, lymfóza - antineoplastické činidlá - xaluprin je indikovaný na liečbu akútnej lymfoblastickej leukémie (all) u dospelých, dospievajúcich a detí.

Európska únia - slovenčina - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - odmietnutie štepu - imunosupresíva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Európska únia - slovenčina - EMA (European Medicines Agency)

xromi

nova laboratories ireland limited - hydroxykarbamid - anémia, kosáčiková bunka - antineoplastické činidlá - prevencia vaso-occlusive komplikácie kosáčikovitá anémia choroby u pacientov nad 2 roky veku.

Európska únia - slovenčina - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolaktón - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 a 5.

Európska únia - slovenčina - EMA (European Medicines Agency)

loxicom

norbrook laboratories (ireland) limited - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats; cattle; pigs - dogsalleviation zápalu a bolesti v akútne a chronické ochorenia pohybového aparátu. znížiť pooperačnú bolesť a zápal po operácii ortopedických a mäkkých tkanív. catsalleviation zápalu a bolesti pri chronických chorobách pohybového ústrojenstva u mačiek. znížiť pooperačnú bolesť po ovariohysterektómii a menšej chirurgii mäkkých tkanív. cattlefor použitie v akútne respiračné infekcie s príslušnými liečba antibiotikami, na zníženie klinických príznakov v chove hovädzieho dobytka. na použitie pri hnačke v kombinácii s perorálnou rehydratáciou na zníženie klinických príznakov u teliat starších ako jeden týždeň a mladých, dojčiacich zvierat. pre doplnkovú liečbu pri liečbe akútnej mastitídy v kombinácii s antibiotickou liečbou. pigsfor použitie v noninfectious pohybového ústrojenstva s cieľom znížiť príznaky lameness a zápal. pre adjunctive terapie v liečbe puerperal septikémiu a toxaemia (mastitis-metritis-agalaktia syndróm) s vhodnej antibiotickej terapie. horsesfor použiť na zmiernenie zápalu a zmiernenie bolesti akútne a chronické ochorenia pohybového aparátu. na úľavu od bolesti spojenej s kolikou koní.